VANI
Vivani Medical Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$103.48M
P/E Ratio
—
EPS
$-0.40
Beta
3.37
52W High
$1.92
52W Low
$0.92
50-Day MA
$1.19
200-Day MA
$1.31
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Vivani Medical Inc.
Vivani Medical Inc. (VANI) is an innovative biotechnology firm dedicated to transforming chronic disease management through its cutting-edge drug delivery technologies. The company develops advanced biocompatible implants designed for sustained medication release, addressing critical health issues such as diabetes and neurological disorders. With a robust product pipeline and a strong intellectual property portfolio, Vivani is well-positioned to meet significant unmet medical needs in the healthcare sector, presenting a compelling investment opportunity for institutional investors seeking exposure to the rapidly evolving biopharmaceutical landscape.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 130,000 |
| EBITDA | $-27.36M |
| Operating Margin | 0.00% |
| Return on Equity | -176.40% |
| Return on Assets | -44.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.23 |
| Price-to-Book | 5.38 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -3.93 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $86.23M |
| Float | $38.86M |
| % Insiders | 57.94% |
| % Institutions | 6.50% |
Historical Volatility
HV 10-Day
48.81%
HV 20-Day
47.62%
HV 30-Day
75.89%
HV 60-Day
68.97%
HV Rank
69.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($4.83 target)
1
Strong Buy2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026